Targeting myeloid epithelial tyrosine kinase (MERTK) receptor in acute myeloid leukemia using a novel antibody-drug conjugate, RGX-019-MMAE

被引：0
|
作者：
Tyagi, Anudishi
Siddiqui, Maryam
Kurth, Isabel
Takeda, Shugaku
Eckstrom, Amanda
Borgman, Jenny
Maiti, Abhishek
Battula, Venkata Lokesh
机构：
来源：
CANCER RESEARCH | 2024年 / 84卷 / 06期
关键词：
D O I：
10.1158/1538-7445.AM2024-6341
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
6341
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Targeting Myeloid Epithelial Tyrosine Kinase (MERTK) Receptor in Acute Myeloid Leukemia Using a Novel Antibody Drug Conjugate, Rgx-019-MMAE
    Tyagi, Anudishi
    Siddiqui, Maryam
    Kurth, Isabel
    Takeda, Shugaku
    Eckstrom, Amanda
    Borgman, Jenny
    Maiti, Abhishek
    Battula, Venkata Lokesh
    BLOOD, 2023, 142
  • [2] RGX-019-MMAE, a novel MERTK-targeting antibody-drug conjugate (ADC) with robust anti-tumor efficacy in both solid and liquid tumors.
    Takeda, Shugaku
    Lo, PuiChi
    Schefer, Daniel
    Andreu-Agullo, Celia
    Battula, Venkata Lokesh
    Maiti, Abhishek
    Tavazoie, Masoud
    Darst, David Martin
    Kurth, Isabel
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [3] Immunotherapeutic Targeting of Mesothelin in Acute Myeloid Leukemia in Vitro with Anetumab Ravtansine and a Novel Antibody-Drug Conjugate
    Kaeding, Allison
    Tarlock, Katherine
    Kolb, E. Anders
    Meshinchi, Soheil
    BLOOD, 2018, 132
  • [4] Targeting receptor tyrosine kinase signaling in acute myeloid leukemia
    Doepfner, Kathrin T.
    Boller, Danielle
    Arcaro, Alexandre
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2007, 63 (03) : 215 - 230
  • [5] An Anti-CLL-1 Antibody-Drug Conjugate for the Treatment of Acute Myeloid Leukemia
    Zheng, Bing
    Yu, Shang-Fan
    del Rosario, Geoffrey
    Leong, Steven R.
    Lee, Genee Y.
    Vij, Rajesh
    Chiu, Cecilia
    Liang, Wei-Ching
    Wu, Yan
    Chalouni, Cecile
    Sadowsky, Jack
    Clark, Vanessa
    Hendricks, Angela
    Poon, Kirsten Achilles
    Chu, Wayne
    Pillow, Thomas
    Schutten, Melissa M.
    Flygare, John
    Polson, Andrew G.
    CLINICAL CANCER RESEARCH, 2019, 25 (04) : 1358 - 1368
  • [6] LILRB4-targeting Antibody-Drug Conjugates for the Treatment of Acute Myeloid Leukemia
    Anami, Yasuaki
    Deng, Mi
    Gui, Xun
    Yamaguchi, Aiko
    Yamazaki, Chisato M.
    Zhang, Ningyan
    Zhang, Chengcheng
    An, Zhiqiang
    Tsuchikama, Kyoji
    MOLECULAR CANCER THERAPEUTICS, 2020, 19 (11) : 2330 - 2339
  • [7] Development of an anti-LAIR1 antibody-drug conjugate for acute myeloid leukemia therapy
    Xu, Weili
    Li, Shuai
    Puan, Kia Joo
    Li, Xueting
    Xu, Caili
    Fan, Jiajun
    Dou, Zihan
    Zhang, Jiquan
    Ju, Dianwen
    INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES, 2025, 293
  • [8] MER RECEPTOR TYROSINE KINASE AS A POTENTIAL NOVEL TARGET IN ACUTE MYELOID LEUKEMIA
    Eisenman, Kristen
    Sather, Susan
    McGranahan, Amy
    Liang, Xiayaun
    Desch, Ashley
    Cannon, Cara
    Martinson, Hollie
    Keating, Amy
    Graham, Doug
    PEDIATRIC BLOOD & CANCER, 2010, 54 (06) : 790 - 790
  • [9] Combinatorial Targeting of the c-KIT Receptor Tyrosine Kinase in Acute Myeloid Leukemia
    Murray, Heather
    Enjeti, Anoop K.
    Kahl, Richard
    Flanagan, Hayley
    Verrills, Nikki
    Dun, Matthew
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2018, 14 : 14 - 14
  • [10] MBRC-101: a novel antibody-drug conjugate (ADC) targeting the tyrosine kinase receptor EphA5
    Staquicini, Fernanda I.
    Tang, Fenny H.
    de Oliveira, Vanessa
    Staquicini, Daniela I.
    Wu, Yongjian
    Barnhart, Kirstin F.
    Parsons, J. Kellogg
    Arap, Wadih
    Chen, Isan
    Pasqualini, Renata
    CANCER RESEARCH, 2024, 84 (06)
12345